The Food and Drug Administration (FDA) inspected Gulf Coast Regional Blood Center in Houston on March 31 to review operations related to blood and blood products, according to data posted on the FDA’s website.
The final inspection report showed that Gulf Coast Regional Blood Center was not required to make any corrections regarding the organization’s managing operations.
The FDA regularly inspects facilities nationwide to verify that workplaces and their products meet FDA-enforced laws and regulations meant to protect public health. These inspection outcomes are made available to the public.
According to its website, the FDA is a federal agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products during production and distribution.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
